Recruiting Lung Cancer Studies in Montreal
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
To assess: * efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification, solid tumors harboring MET amplification, solid...
Volrustomig Priming Regimens Exploratory Phase II Platform Study
Purpose of this study is to assess the safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of volrustomig in combination with other anticancer drugs in participants with spe...
About Lung Cancer Clinical Trials in Montreal
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Montreal, QUEBEC. These studies are seeking a combined 677 participants. Research is being sponsored by Apollomics Inc., AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Montreal — FAQ
Are there lung cancer clinical trials in Montreal?
Yes, there are 2 lung cancer clinical trials currently recruiting in Montreal, QUEBEC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Montreal?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Montreal research site will contact you about next steps.
Are clinical trials in Montreal free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Montreal studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Montreal are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov